PARP
PARP(多聚ADP核糖聚合酶)
Poly (ADP-ribose) polymerases (PARPs) is a large family of proteins with a conserved catalytic domain that catalyze an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins leading to the survival of injured proliferating cells. So far, a total number of 18 human PARP proteins encoded by different genes have been identified, including PARP-1 to PARP-4, PARP-5a, PARP-5b, PARP-5c and PARP-6 to PARP-16. The general structural of PARP proteins has been revealed through the extensive study of the founding family member PARP-1, which is characterized by the presence of four functional domains, including a DNA-binding domain, a caspase-cleaved domain, an automodification domain and a catalytic domain.
PARP 相关产品(120)
- GC351505,7,4'-TrimethoxyflavoneCAS: 5631-70-9纯度: >99.50%
4',5,7-Trimethoxyflavone (5,7,4'-Trimethoxyflavone, TMF) is a flavonoid isolated from Kaempferia parviflora (KP) that induces apoptosis. 4',5,7-Trimethoxyflavone increases sub-G1 phase, DNA fragmentation, annexin-V/PI staining and Bax/Bcl-xL ratio, activates caspase-3 and degrades poly (ADP-ribose) polymerase (PARP) protein.
- GC35550BRCA1-IN-2CAS: 1622262-55-8纯度: >98.00%
BRCA1-IN-2 (compound 15) 是具有细胞渗透性的 BRCA1 蛋白-蛋白相互作用 (PPI) 的抑制剂,IC50 值 0.31 μM,Kd 值为 0.3 μM, BRCA1-IN-2 通过阻断 BRCA1 (BRCT)2/ 蛋白质相互作用而具有抗肿瘤活性。
- GC36855Paris saponin VIICAS: 68124-04-9纯度: >98.00% / >98.50%
Chonglou Saponin VII (Dioscinin, Polyphyllin-VII, Paris saponin-VII), a kind of steroidal saponins from Chonglou (Rhizoma Paridis Chonglou), inhibits EMT and reduces the invasion of ovarian cancer cells via the GSK-3β/β-catenin signaling pathway.
- GC37728Talazoparib tosylateCAS: 1373431-65-2纯度: >99.50%
Talazoparib tosylate(BMN 673ts)是一种有效的具有口服活性的PARP1/2抑制剂,是Talazoparib的甲苯磺酸盐形式。Talazoparib抑制PARP1的IC 50 值为0.57nM。
- GC39302PARP14 inhibitor H10CAS: 2084811-68-5纯度: >98.00%
PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。
- GC62121FluzoparibCAS: 1358715-18-0纯度: >98.00%
Fluzoparib (SHR3162, HS10160) is a potent Poly (ADP-ribose) polymerase (PARP) inhibitor that shows anti-tumor activity.
- GC62129VenadaparibCAS: 1681017-83-3纯度: >98.00%
Venadaparib (IDX-1197), a potent PARP1/2 inhibitor with IC50 values of 1.4 nM and 1.0 nM respectively, prevents the repair of DNA single-strand breaks (SSB) and promotes the conversion of SSB to double-stranded breaks (DSB), which ultimately leads to synthetic lethality in cancer cells.
- GC62154N-Descyclopropanecarbaldehyde OlaparibCAS: 763111-47-3纯度: >99.00%
N-Descyclopropanecarbaldehyde Olaparib 是含有 DOTA 的奥拉帕尼的类似物。Descyclopropanecarbaldehyde Olaparib 是一种 CRBN 配体,可用于合成新型靶向 EGFR 和 PARP 的双靶点 PROTAC,DP-C-4。N-Descyclopropanecarbaldehyde Olaparib 可以用 F-18 或荧光团进行放射性标记用于正电子发射断层扫描 (PET) 或几种类型的肿瘤的光学成像。
- GC62252Mefuparib hydrochlorideCAS: 1449746-00-2纯度: >98.00%
Mefuparib hydrochloride (MPH) 是一种具有口服活性的,底物竞争性和选择性的 PARP1/2 抑制剂,IC50 分别为 3.2 nM 和 1.9 nM。Mefuparib hydrochloride 诱导细胞凋亡 (apoptosis),并在体内外具有显着的抗癌活性。
- GC62275PARP1-IN-5 dihydrochlorideCAS: 2823308-89-8
PARP1-IN-5 dihydrochloride 是一种低毒、具有口服活性、有效的和有选择性的 PARP-1 抑制剂(IC50 =14.7 nM)。PARP1-IN-5 dihydrochloride 可用于癌症研究。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC34195 | K-756 | 130017-40-2 | >99.00% | |
K-756是一种直接的选择性tankyrase(TNKS)抑制剂,抑制TNKS1和TNKS2的ADP-核糖基化活性,IC50分别为31和36nM。 | ||||
| GC35150 | 5,7,4'-Trimethoxyflavone | 5631-70-9 | >99.50% | |
4',5,7-Trimethoxyflavone (5,7,4'-Trimethoxyflavone, TMF) is a flavonoid isolated from Kaempferia parviflora (KP) that induces apoptosis. 4',5,7-Trimethoxyflavone increases sub-G1 phase, DNA fragmentation, annexin-V/PI staining and Bax/Bcl-xL ratio, activates caspase-3 and degrades poly (ADP-ribose) polymerase (PARP) protein. | ||||
| GC35547 | BR102375 | 2366255-59-4 | - | |
BR102375 是一种用于治疗 2 型糖尿病的 non-TZD (噻唑烷二酮类) PPAR γ 完全激动剂, 其 EC50 值和 Amax比率值分别为 0.28 μM 和 98%。 | ||||
| GC35550 | BRCA1-IN-2 | 1622262-55-8 | >98.00% | |
BRCA1-IN-2 (compound 15) 是具有细胞渗透性的 BRCA1 蛋白-蛋白相互作用 (PPI) 的抑制剂,IC50 值 0.31 μM,Kd 值为 0.3 μM, BRCA1-IN-2 通过阻断 BRCA1 (BRCT)2/ 蛋白质相互作用而具有抗肿瘤活性。 | ||||
| GC36751 | NMS-P515 | 1262395-13-0 | - | |
NMS-P515 是有效的、口服有效的、立体定向的PARP-1 的抑制剂,Kd 值为16 nM,IC50 值为 27 nM (Hela 细胞中)。有抗肿瘤活性。 | ||||
| GC36855 | Paris saponin VII | 68124-04-9 | >98.00% / >98.50% | |
Chonglou Saponin VII (Dioscinin, Polyphyllin-VII, Paris saponin-VII), a kind of steroidal saponins from Chonglou (Rhizoma Paridis Chonglou), inhibits EMT and reduces the invasion of ovarian cancer cells via the GSK-3β/β-catenin signaling pathway. | ||||
| GC37728 | Talazoparib tosylate | 1373431-65-2 | >99.50% | |
Talazoparib tosylate(BMN 673ts)是一种有效的具有口服活性的PARP1/2抑制剂,是Talazoparib的甲苯磺酸盐形式。Talazoparib抑制PARP1的IC 50 值为0.57nM。 | ||||
| GC37735 | Tankyrase-IN-2 | 1588870-36-3 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC39302 | PARP14 inhibitor H10 | 2084811-68-5 | >98.00% | |
PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。 | ||||
| GC40468 | 1,5-Isoquinolinediol | 5154-02-9 | >99.00% | |
An inhibitor of poly(ADP-ribose) polymerases | ||||
| GC45772 | 6(5H)-Phenanthridinone | 1015-89-0 | >98.00% | |
An inhibitor of PARP1 and 2 | ||||
| GC45808 | OUL35 | 6336-34-1 | >99.00% | |
An inhibitor of PARP10 | ||||
| GC46900 | AZ9482 | 1825345-33-2 | >98.00% | |
A PARP inhibitor | ||||
| GC47055 | CAY10749 | 2337386-47-5 | >98.00% | |
A dual inhibitor of PARP and PI3K | ||||
| GC47056 | CAY10753 | - | >98.00% | |
A TNKS2 inhibitor | ||||
| GC47693 | m-Methoxybenzamide | 5813-86-5 | >98.00% | |
A PARP inhibitor | ||||
| GC50506 | Fluorescein-NAD+ | - | - | |
荧光素-NAD+ 是放射性标记的 NAD 的替代品,也是 ADP 核糖基化的底物。 | ||||
| GC62105 | Senaparib | 1401682-78-7 | >99.00% | |
Senaparib (IMP4297) 是强效的、选择性的、口服有效的 PARP1/2 抑制剂。Senaparib (IMP4297) 在动物模型中表现强效的抗肿瘤活性。 | ||||
| GC62121 | Fluzoparib | 1358715-18-0 | >98.00% | |
Fluzoparib (SHR3162, HS10160) is a potent Poly (ADP-ribose) polymerase (PARP) inhibitor that shows anti-tumor activity. | ||||
| GC62129 | Venadaparib | 1681017-83-3 | >98.00% | |
Venadaparib (IDX-1197), a potent PARP1/2 inhibitor with IC50 values of 1.4 nM and 1.0 nM respectively, prevents the repair of DNA single-strand breaks (SSB) and promotes the conversion of SSB to double-stranded breaks (DSB), which ultimately leads to synthetic lethality in cancer cells. | ||||
| GC62154 | N-Descyclopropanecarbaldehyde Olaparib | 763111-47-3 | >99.00% | |
N-Descyclopropanecarbaldehyde Olaparib 是含有 DOTA 的奥拉帕尼的类似物。Descyclopropanecarbaldehyde Olaparib 是一种 CRBN 配体,可用于合成新型靶向 EGFR 和 PARP 的双靶点 PROTAC,DP-C-4。N-Descyclopropanecarbaldehyde Olaparib 可以用 F-18 或荧光团进行放射性标记用于正电子发射断层扫描 (PET) 或几种类型的肿瘤的光学成像。 | ||||
| GC62252 | Mefuparib hydrochloride | 1449746-00-2 | >98.00% | |
Mefuparib hydrochloride (MPH) 是一种具有口服活性的,底物竞争性和选择性的 PARP1/2 抑制剂,IC50 分别为 3.2 nM 和 1.9 nM。Mefuparib hydrochloride 诱导细胞凋亡 (apoptosis),并在体内外具有显着的抗癌活性。 | ||||
| GC62275 | PARP1-IN-5 dihydrochloride | 2823308-89-8 | - | |
PARP1-IN-5 dihydrochloride 是一种低毒、具有口服活性、有效的和有选择性的 PARP-1 抑制剂(IC50 =14.7 nM)。PARP1-IN-5 dihydrochloride 可用于癌症研究。 | ||||
| GC62310 | AZD5305 | 2589531-76-8 | >99.50% | |
AZD5305高选择性PARP1抑制剂,通过精准靶向PARP1破坏肿瘤细胞的DNA损伤修复机制,从而诱导癌细胞死亡,AZD5305对PARP1(IC 50 =3nM)的选择性比PARP2(IC 50 =1400nM)高约500倍。 | ||||
